Delvosteron 100 mg/ml Injektionssuspension für Hunde und Katzen
Delvosteron 100 mg/ml Injektionssuspension für Hunde und Katzen
Not authorised
- Proligestone
Product identification
Medicine name:
Delvosteron 100 mg/ml Injektionssuspension für Hunde und Katzen
Active substance:
- Proligestone
Target species:
-
Dog
-
Cat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Proligestone100.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QG03DA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Austria
Package description:
- Available only in German
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet Ges.m.b.H.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Austrian Agency For Health And Food Safety
Authorisation number:
- 8-00011
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 19/08/2016
Updated on: 28/11/2025
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 19/08/2016
Updated on: 28/11/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 21/06/2013
Updated on: 28/11/2025
at-puar-600000075806-np-delvoesteroen-de.pdf
German (PDF)
Download Published on: 19/11/2013
Updated on: 28/11/2025